ToxStrategies Acquires Suttons Creek
Partnership between leading pharmaceutical solution providers enhances offerings across pharmaceutical development and commercialization August 13, 2024 –Katy, Texas — ToxStrategies, a leading multidisciplinary scientific consulting firm, today announced the acquisition of Suttons Creek. Founded in 2012 by Steven Badelt, PhD, Suttons Creek offers comprehensive consulting and execution services for combination product development across each phase of the product lifecycle. These product development services include quality, regulatory, human factors and usability engineering, strategy consulting, training read more…
